Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest & Investment Income (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Interest & Investment Income for 6 consecutive years, with -$520000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 25.5% to -$520000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.5 million, a 16.26% increase, with the full-year FY2025 number at -$2.5 million, up 16.26% from a year prior.
  • Interest & Investment Income was -$520000.0 for Q4 2025 at GeneDx Holdings, up from -$562000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q4 2022 to a low of -$978000.0 in Q4 2023.
  • A 5-year average of -$123150.0 and a median of -$165500.0 in 2021 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 5063.64% in 2022, then tumbled 186.09% in 2023.
  • GeneDx Holdings' Interest & Investment Income stood at $22000.0 in 2021, then surged by 5063.64% to $1.1 million in 2022, then crashed by 186.09% to -$978000.0 in 2023, then increased by 28.63% to -$698000.0 in 2024, then rose by 25.5% to -$520000.0 in 2025.
  • Per Business Quant, the three most recent readings for WGS's Interest & Investment Income are -$520000.0 (Q4 2025), -$562000.0 (Q3 2025), and -$817000.0 (Q2 2025).